These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21944757)

  • 1. Targeted disruption of the CCR5 gene in human hematopoietic stem cells stimulated by peptide nucleic acids.
    Schleifman EB; Bindra R; Leif J; del Campo J; Rogers FA; Uchil P; Kutsch O; Shultz LD; Kumar P; Greiner DL; Glazer PM
    Chem Biol; 2011 Sep; 18(9):1189-98. PubMed ID: 21944757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo.
    Xu L; Yang H; Gao Y; Chen Z; Xie L; Liu Y; Liu Y; Wang X; Li H; Lai W; He Y; Yao A; Ma L; Shao Y; Zhang B; Wang C; Chen H; Deng H
    Mol Ther; 2017 Aug; 25(8):1782-1789. PubMed ID: 28527722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo.
    Bai J; Gorantla S; Banda N; Cagnon L; Rossi J; Akkina R
    Mol Ther; 2000 Mar; 1(3):244-54. PubMed ID: 10933940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases.
    Li L; Krymskaya L; Wang J; Henley J; Rao A; Cao LF; Tran CA; Torres-Coronado M; Gardner A; Gonzalez N; Kim K; Liu PQ; Hofer U; Lopez E; Gregory PD; Liu Q; Holmes MC; Cannon PM; Zaia JA; DiGiusto DL
    Mol Ther; 2013 Jun; 21(6):1259-69. PubMed ID: 23587921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticles deliver triplex-forming PNAs for site-specific genomic recombination in CD34+ human hematopoietic progenitors.
    McNeer NA; Chin JY; Schleifman EB; Fields RJ; Glazer PM; Saltzman WM
    Mol Ther; 2011 Jan; 19(1):172-80. PubMed ID: 20859257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivo.
    McNeer NA; Schleifman EB; Cuthbert A; Brehm M; Jackson A; Cheng C; Anandalingam K; Kumar P; Shultz LD; Greiner DL; Mark Saltzman W; Glazer PM
    Gene Ther; 2013 Jun; 20(6):658-69. PubMed ID: 23076379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template.
    Sather BD; Romano Ibarra GS; Sommer K; Curinga G; Hale M; Khan IF; Singh S; Song Y; Gwiazda K; Sahni J; Jarjour J; Astrakhan A; Wagner TA; Scharenberg AM; Rawlings DJ
    Sci Transl Med; 2015 Sep; 7(307):307ra156. PubMed ID: 26424571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CCR5 Gene Edited CD34
    Karuppusamy KV; Demosthenes JP; Venkatesan V; Christopher AC; Babu P; Azhagiri MK; Jacob A; Ramalingam VV; Rangaraj S; Murugesan MK; Marepally SK; Varghese GM; Srivastava A; Kannangai R; Thangavel S
    Front Immunol; 2022; 13():792684. PubMed ID: 35359982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers Functional and Persistent HIV-1 Resistance in Humanized Mice.
    Myburgh R; Ivic S; Pepper MS; Gers-Huber G; Li D; Audigé A; Rochat MA; Jaquet V; Regenass S; Manz MG; Salmon P; Krause KH; Speck RF
    J Virol; 2015 Jul; 89(13):6761-72. PubMed ID: 25903342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of HIV-1 co-receptors CCR5 and CXCR4 in primary human T cells and hematopoietic stem and progenitor cells using base editing.
    Knipping F; Newby GA; Eide CR; McElroy AN; Nielsen SC; Smith K; Fang Y; Cornu TI; Costa C; Gutierrez-Guerrero A; Bingea SP; Feser CJ; Steinbeck B; Hippen KL; Blazar BR; McCaffrey A; Mussolino C; Verhoeyen E; Tolar J; Liu DR; Osborn MJ
    Mol Ther; 2022 Jan; 30(1):130-144. PubMed ID: 34737067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatin structure of two genomic sites for targeted transgene integration in induced pluripotent stem cells and hematopoietic stem cells.
    van Rensburg R; Beyer I; Yao XY; Wang H; Denisenko O; Li ZY; Russell DW; Miller DG; Gregory P; Holmes M; Bomsztyk K; Lieber A
    Gene Ther; 2013 Feb; 20(2):201-14. PubMed ID: 22436965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine receptor 5 knockout strategies.
    Cannon P; June C
    Curr Opin HIV AIDS; 2011 Jan; 6(1):74-9. PubMed ID: 21242897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triplex-forming peptide nucleic acids induce heritable elevations in gamma-globin expression in hematopoietic progenitor cells.
    Chin JY; Reza F; Glazer PM
    Mol Ther; 2013 Mar; 21(3):580-7. PubMed ID: 23337982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy.
    Bai J; Rossi J; Akkina R
    AIDS Res Hum Retroviruses; 2001 Mar; 17(5):385-99. PubMed ID: 11282007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR5 as a natural and modulated target for inhibition of HIV.
    Burke BP; Boyd MP; Impey H; Breton LR; Bartlett JS; Symonds GP; Hütter G
    Viruses; 2013 Dec; 6(1):54-68. PubMed ID: 24381033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR5-targeted hematopoietic stem cell gene approaches for HIV disease: current progress and future prospects.
    Lai Y
    Curr Stem Cell Res Ther; 2012 Jul; 7(4):310-7. PubMed ID: 22486585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT mice.
    Ringpis GE; Shimizu S; Arokium H; Camba-Colón J; Carroll MV; Cortado R; Xie Y; Kim PY; Sahakyan A; Lowe EL; Narukawa M; Kandarian FN; Burke BP; Symonds GP; An DS; Chen IS; Kamata M
    PLoS One; 2012; 7(12):e53492. PubMed ID: 23300932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector.
    Walker JE; Chen RX; McGee J; Nacey C; Pollard RB; Abedi M; Bauer G; Nolta JA; Anderson JS
    J Virol; 2012 May; 86(10):5719-29. PubMed ID: 22398281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo.
    Holt N; Wang J; Kim K; Friedman G; Wang X; Taupin V; Crooks GM; Kohn DB; Gregory PD; Holmes MC; Cannon PM
    Nat Biotechnol; 2010 Aug; 28(8):839-47. PubMed ID: 20601939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editing CCR5: a novel approach to HIV gene therapy.
    Cornu TI; Mussolino C; Bloom K; Cathomen T
    Adv Exp Med Biol; 2015; 848():117-30. PubMed ID: 25757618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.